ROS1 Gene Mutation Active Not Recruiting Phase 2 Trials for SEphB4-HSA (DB14797)

IndicationStatusPhase
DBCOND0082893 (ROS1 Gene Mutation)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03049618Recombinant EphB4-HSA Fusion Protein and Pembrolizumab, MK-3475Treatment